{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:18:03Z","timestamp":1793744283750,"version":"4.6.1"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Alloreactive donor T cells undergo extensive metabolic reprogramming to become activated and induce graft-versus-host disease (GVHD) upon alloantigen encounter. It is generally thought that glycolysis, which promotes T cell growth and clonal expansion, is employed in this process. However, conflicting data have been reported regarding the requirement of glycolysis to induce T cell-mediated GVHD due to the lack of T cell-specific treatments using glycolysis inhibitors. Importantly, previous studies have not evaluated whether graft-versus-leukemia (GVL) activity is preserved in donor T cells deficient for glycolysis. As a critical component affecting the clinical outcome, it is necessary to assess the anti-tumor activity following treatment with metabolic modulators in preclinical models. In the present study, we utilized T cells selectively deficient for glucose transporter 1 (Glut1<jats:sup>T-KO<\/jats:sup>), to examine the role of glycolysis exclusively in alloreactive T cells without off-targeting effects from antigen presenting cells and other cell types that are dependent on glycolysis. We demonstrated that transfer of Glut1<jats:sup>T-KO<\/jats:sup> T cells significantly improved acute GVHD outcomes through increased apoptotic rates, impaired expansion, and decreased proinflammatory cytokine production. In addition to impaired GVHD development, donor Glut1<jats:sup>T-KO<\/jats:sup> T cells mediated sufficient GVL activity to protect recipients from tumor development. A clinically relevant approach using donor T cells treated with a small molecule inhibitor of glycolysis, 2-Deoxy-D-glucose ex vivo, further demonstrated protection from tumor development. These findings indicate that treatment with glycolysis inhibitors prior to transplantation selectively eliminates alloreactive T cells, but spares non-alloreactive T cells including those that protect against tumor growth. The present study has established a definitive role for glycolysis in acute GVHD and demonstrated that acute GVHD can be selectively prevented through targeting glycolysis.<\/jats:p>","DOI":"10.3389\/fimmu.2022.751296","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T07:48:25Z","timestamp":1646034505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect"],"prefix":"10.3389","volume":"13","author":[{"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfeng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancie J.","family":"MacIver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana\u00a0M.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd V.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson J.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey\u00a0C.","family":"Rathmell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-Versus-Host Disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet (Lond Engl)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk Factors for Acute GVHD and Survival After Hematopoietic Cell Transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1609337","article-title":"Acute Graft-Versus-Host Disease - Biologic Process, Prevention, and Therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.7.1423.1423","article-title":"Increased Risk of Leukemia Relapse With High-Dose Cyclosporine A After Allogeneic Marrow Transplantation for Acute Leukemia","volume":"77","author":"Bacigalupo","year":"1991","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1572.005k12_1572_1579","article-title":"Graft Versus Host Disease Prophylaxis With Low-Dose Cyclosporine-A Reduces the Risk of Relapse in Children With Acute Leukemia Given HLA-Identical Sibling Bone Marrow Transplantation: Results of a Randomized Trial","volume":"95","author":"Locatelli","year":"2000","journal-title":"Blood"},{"key":"B6","article-title":"Effect of Graft-Versus-Host Disease Prophylaxis on Relapse in Patients Transplanted for Acute Myeloid Leukemia","volume":"14","author":"Weaver","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001975","article-title":"Manipulating the Bioenergetics of Alloreactive T Cells Causes Their Selective Apoptosis and Arrests Graft-Versus-Host Disease","volume":"3","author":"Gatza","year":"2011","journal-title":"Sci Trans Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic Coordination of T Cell Quiescence and Activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1242454","article-title":"Fueling Immunity: Insights Into Metabolism and Lymphocyte Function","volume":"342","author":"Pearce","year":"2013","journal-title":"Sci (New York NY)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.01.040","article-title":"Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions","volume":"22","author":"Menk","year":"2018","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21330","article-title":"Glycolysis and Glutaminolysis Cooperatively Control T Cell Function by Limiting Metabolite Supply to N-Glycosylation","volume":"6","author":"Araujo","year":"2017","journal-title":"eLife"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00833","article-title":"Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-018-1095-7","article-title":"Enhanced Glycolysis Contributes to the Pathogenesis of Experimental Autoimmune Neuritis","volume":"15","author":"Liu","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1101\/2020.02.05.935627","article-title":"Human CD8+ T-Cells Require Glycolysis to Elicit Effector Function","volume-title":"bioRxiv","author":"Stimpson","year":"2020"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-495515","article-title":"Effector T Cells Require Fatty Acid Metabolism During Murine Graft-Versus-Host Disease","volume":"122","author":"Byersdorfer","year":"2013","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1124\/jpet.114.218099","article-title":"Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach to Treat Graft-Versus-Host Disease","volume":"351","author":"Glick","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0108024","article-title":"Glucose Metabolism in Lymphocytes is a Regulated Process With Significant Effects on Immune Cell Function and Survival","volume":"84","author":"Maciver","year":"2008","journal-title":"J leukocyte Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI82587","article-title":"Metabolic Reprogramming of Alloantigen-Activated T Cells After Hematopoietic Cell Transplantation","volume":"126","author":"Nguyen","year":"2016","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2833","article-title":"TLR-Driven Early Glycolytic Reprogramming via the Kinases TBK1-IKK\u03b5 Supports the Anabolic Demands of Dendritic Cell Activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-419747","article-title":"Commitment to Glycolysis Sustains Survival of NO-Producing Inflammatory Dendritic Cells","volume":"120","author":"Everts","year":"2012","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-Like Receptor\u2013Induced Changes in Glycolytic Metabolism Regulate Dendritic Cell Activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400954","article-title":"Programmed Death-1 Pathway in Host Tissues Ameliorates Th17\/Th1-Mediated Experimental Chronic Graft-Versus-Host Disease","volume":"193","author":"Fujiwara","year":"2014","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-500801","article-title":"Host Programmed Death Ligand 1 is Dominant Over Programmed Death Ligand 2 Expression in Regulating Graft-Versus-Host Disease Lethality","volume":"122","author":"Saha","year":"2013","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4476","article-title":"Glucose Uptake is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways","volume":"180","author":"Jacobs","year":"2008","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31815e883e","article-title":"A New T-Cell Receptor Transgenic Model of the CD4+ Direct Pathway: Level of Priming Determines Acute Versus Chronic Rejection","volume":"85","author":"Brennan","year":"2008","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02578.x","article-title":"Preferential Priming of Alloreactive T Cells With Indirect Reactivity","volume":"9","author":"Brennan","year":"2009","journal-title":"Am J Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023205","article-title":"Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo","volume":"6","author":"Young","year":"2011","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-016410","article-title":"Inability of Memory T Cells to Induce Graft-Versus-Host Disease Is a Result of an Abortive Alloresponse","volume":"109","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302062","article-title":"Metabolic Reprogramming is Required for Antibody Production That Is Suppressed in Anergic But Exaggerated in Chronically BAFF-Exposed B Cells","volume":"192","author":"Caro-Maldonado","year":"2014","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The Transcription Factor Myc Controls Metabolic Reprogramming Upon T Lymphocyte Activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nri3198","article-title":"Regulation and Function of mTOR Signalling in T Cell Fate Decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00153-07","article-title":"Glycogen Synthase Kinase 3alpha and 3beta Mediate a Glucose-Sensitive Antiapoptotic Signaling Pathway to Stabilize Mcl-1","volume":"27","author":"Zhao","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008763","article-title":"Metabolic Stress in Autophagy and Cell Death Pathways","volume":"4","author":"Altman","year":"2012","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.06.005","article-title":"Apoptosis Threshold Set by Noxa and Mcl-1 After T Cell Activation Regulates Competitive Selection of High-Affinity Clones","volume":"32","author":"Wensveen","year":"2010","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-011-0599-8","article-title":"Apoptosis Induced by Overall Metabolic Stress Converges on the Bcl-2 Family Proteins Noxa and Mcl-1","volume":"16","author":"Wensveen","year":"2011","journal-title":"Apoptosis: Int J Programmed Cell Death"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200176","article-title":"Anticancer Agents That Counteract Tumor Glycolysis","volume":"7","author":"Granchi","year":"2012","journal-title":"ChemMedChem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-006-0207-8","article-title":"Efficacy of 2-Halogen Substituted D-Glucose Analogs in Blocking Glycolysis and Killing \u201cHypoxic Tumor Cells","volume":"58","author":"Lampidis","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)85017-6","article-title":"Improving Cancer Radiotherapy With 2-Deoxy-D-Glucose: Phase I\/II Clinical Trials on Human Cerebral Gliomas","volume":"35","author":"Mohanti","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1038\/s41467-018-06686-0","article-title":"Inhibition of Glucose Metabolism Selectively Targets Autoreactive Follicular Helper T Cells","volume":"9","author":"Choi","year":"2018","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-2045-1","article-title":"A Phase I Dose-Escalation Trial of 2-Deoxy-D-Glucose Alone or Combined With Docetaxel in Patients With Advanced Solid Tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21172","article-title":"Targeting Tumor Metabolism With 2-Deoxyglucose in Patients With Castrate-Resistant Prostate Cancer and Advanced Malignancies","volume":"70","author":"Stein","year":"2010","journal-title":"Prostate"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T Cell Metabolism Reverses Lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Trans Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151159","article-title":"T Cell Metabolism Drives Immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005770","article-title":"Glycolytic Metabolism of Pathogenic T Cells Enables Early Detection of GVHD by 13C-MRI","volume":"137","author":"Assmann","year":"2021","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119164","article-title":"Clinical Molecular Imaging in Intestinal Graft-Versus-Host Disease: Mapping of Disease Activity, Prediction, and Monitoring of Treatment Efficiency by Positron Emission Tomography","volume":"111","author":"Stelljes","year":"2008","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP Activity Is Regulated by Mtorc1 and Contributes to Akt-Dependent Cell Growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of Immune Responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of Metabolism and Mitochondrial Homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.179101","article-title":"Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells","volume":"286","author":"Coloff","year":"2011","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803580200","article-title":"Glucose Metabolism Attenuates P53 and Puma-Dependent Cell Death Upon Growth Factor Deprivation","volume":"283","author":"Zhao","year":"2008","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.448","article-title":"Glycolysis Inhibition Sensitizes Tumor Cells to Death Receptors-Induced Apoptosis by AMP Kinase Activation Leading to Mcl-1 Block in Translation","volume":"29","author":"Pradelli","year":"2010","journal-title":"Oncogene"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.06.009","article-title":"Mule\/ARF-BP1, a BH3-Only E3 Ubiquitin Ligase, Catalyzes the Polyubiquitination of Mcl-1 and Regulates Apoptosis","volume":"121","author":"Zhong","year":"2005","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M610643200","article-title":"Rapid Turnover of Mcl-1 Couples Translation to Cell Survival and Apoptosis","volume":"282","author":"Adams","year":"2007","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545473","article-title":"Metabolic Plasticity of Human T Cells: Preserved Cytokine Production Under Glucose Deprivation or Mitochondrial Restriction, But 2-Deoxy-Glucose Affects Effector Functions","volume":"45","author":"Renner","year":"2015","journal-title":"Eur J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of High-Risk Acute Leukemia With T-Cell-Depleted Stem Cells From Related Donors With One Fully Mismatched HLA Haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"New Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.2.383","article-title":"The Number of Donor CD3(+) Cells Is the Most Important Factor for Graft Failure After Allogeneic Transplantation of CD34(+) Selected Cells From Peripheral Blood From HLA-Identical Siblings","volume":"97","author":"Urbano-Ispizua","year":"2001","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-11-0057","article-title":"Risk Factors for Acute Graft-Versus-Host Disease in Patients Undergoing Transplantation With CD34+ Selected Blood Cells From HLA-Identical Siblings","volume":"100","author":"Urbano-Ispizua","year":"2002","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12026-010-8193-7","article-title":"Prevention of GVHD Without Losing GVL Effect: Windows of Opportunity","volume":"49","author":"Zhang","year":"2011","journal-title":"Immunol Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial Dynamics Controls T Cell Fate Through Metabolic Programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69589","article-title":"Inhibiting Glycolytic Metabolism Enhances CD8+ T Cell Memory and Antitumor Function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J Clin Invest"},{"key":"B66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","article-title":"Metabolic Switching and Fuel Choice During T-Cell Differentiation and Memory Development","volume":"249","author":"van der Windt","year":"2012","journal-title":"Immunol Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb8969","article-title":"Metabolic Reprogramming of Donor T Cells Enhances Graft-Versus-Leukemia Effects in Mice and Humans","volume":"12","author":"Uhl","year":"2020","journal-title":"Sci Trans Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0219-4","article-title":"Inosine Is an Alternative Carbon Source for CD8(+)-T-Cell Function Under Glucose Restriction","volume":"2","author":"Wang","year":"2020","journal-title":"Nat Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.1.288.288","article-title":"Attenuation of Graft-Versus-Host Disease and Graft Rejection by Ex Vivo Immunotoxin Elimination of Alloreactive T Cells in an H-2 Haplotype Disparate Mouse Combination","volume":"83","author":"Cavazzana-Calvo","year":"1994","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.9.3083","article-title":"Prevention of Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect After Selective Depletion of Host-Reactive T Cells by Photodynamic Cell Purging Process","volume":"99","author":"Chen","year":"2002","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of Anergic Histoincompatible Bone Marrow Allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.751296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T07:48:28Z","timestamp":1646034508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.751296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2022.751296"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.751296","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"article-number":"751296"}}